Bispecific Monoclonal Antibodies Market - Global Outlook and Forecast 2021-2027

March 2021 | 93 pages | ID: BA4DF13A2395EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Bispecific Monoclonal Antibodies in Global, including the following market information:

Global Bispecific Monoclonal Antibodies Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Bispecific Monoclonal Antibodies market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bispecific Monoclonal Antibodies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bispecific Monoclonal Antibodies Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Bispecific Monoclonal Antibodies Market Segment Percentages, By Type, 2020 (%)

• Fragment-Based Antibodies
• IgG-Based Antibodies

China Bispecific Monoclonal Antibodies Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Bispecific Monoclonal Antibodies Market Segment Percentages, By Application, 2020 (%)

• Cancer
• Haemophilia
• Other Non-Cancer Diseases

Global Bispecific Monoclonal Antibodies Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Bispecific Monoclonal Antibodies Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Bispecific Monoclonal Antibodies Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Bispecific Monoclonal Antibodies Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Roche (Chugai)
• Amgen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bispecific Monoclonal Antibodies Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bispecific Monoclonal Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BISPECIFIC MONOCLONAL ANTIBODIES OVERALL MARKET SIZE

2.1 Global Bispecific Monoclonal Antibodies Market Size: 2021 VS 2027
2.2 Global Bispecific Monoclonal Antibodies Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bispecific Monoclonal Antibodies Players in Global Market
3.2 Top Global Bispecific Monoclonal Antibodies Companies Ranked by Revenue
3.3 Global Bispecific Monoclonal Antibodies Revenue by Companies
3.4 Top 3 and Top 5 Bispecific Monoclonal Antibodies Companies in Global Market, by Revenue in 2020
3.5 Global Companies Bispecific Monoclonal Antibodies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bispecific Monoclonal Antibodies Players in Global Market
  3.6.1 List of Global Tier 1 Bispecific Monoclonal Antibodies Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bispecific Monoclonal Antibodies Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Bispecific Monoclonal Antibodies Market Size Markets, 2021 & 2027
  4.1.2 Fragment-Based Antibodies
  4.1.3 IgG-Based Antibodies
4.2 By Type - Global Bispecific Monoclonal Antibodies Revenue & Forecasts
  4.2.1 By Type - Global Bispecific Monoclonal Antibodies Revenue, 2016-2021
  4.2.2 By Type - Global Bispecific Monoclonal Antibodies Revenue, 2022-2027
  4.2.3 By Type - Global Bispecific Monoclonal Antibodies Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bispecific Monoclonal Antibodies Market Size, 2021 & 2027
  5.1.2 Cancer
  5.1.3 Haemophilia
  5.1.4 Other Non-Cancer Diseases
5.2 By Application - Global Bispecific Monoclonal Antibodies Revenue & Forecasts
  5.2.1 By Application - Global Bispecific Monoclonal Antibodies Revenue, 2016-2021
  5.2.2 By Application - Global Bispecific Monoclonal Antibodies Revenue, 2022-2027
  5.2.3 By Application - Global Bispecific Monoclonal Antibodies Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Bispecific Monoclonal Antibodies Market Size, 2021 & 2027
6.2 By Region - Global Bispecific Monoclonal Antibodies Revenue & Forecasts
  6.2.1 By Region - Global Bispecific Monoclonal Antibodies Revenue, 2016-2021
  6.2.2 By Region - Global Bispecific Monoclonal Antibodies Revenue, 2022-2027
  6.2.3 By Region - Global Bispecific Monoclonal Antibodies Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Bispecific Monoclonal Antibodies Revenue, 2016-2027
  6.3.2 US Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.3.3 Canada Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.3.4 Mexico Bispecific Monoclonal Antibodies Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Bispecific Monoclonal Antibodies Revenue, 2016-2027
  6.4.2 Germany Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.4.3 France Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.4.4 U.K. Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.4.5 Italy Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.4.6 Russia Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.4.7 Nordic Countries Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.4.8 Benelux Bispecific Monoclonal Antibodies Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Bispecific Monoclonal Antibodies Revenue, 2016-2027
  6.5.2 China Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.5.3 Japan Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.5.4 South Korea Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.5.5 Southeast Asia Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.5.6 India Bispecific Monoclonal Antibodies Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Bispecific Monoclonal Antibodies Revenue, 2016-2027
  6.6.2 Brazil Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.6.3 Argentina Bispecific Monoclonal Antibodies Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bispecific Monoclonal Antibodies Revenue, 2016-2027
  6.7.2 Turkey Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.7.3 Israel Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.7.4 Saudi Arabia Bispecific Monoclonal Antibodies Market Size, 2016-2027
  6.7.5 UAE Bispecific Monoclonal Antibodies Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Roche (Chugai)
  7.1.1 Roche (Chugai) Corporate Summary
  7.1.2 Roche (Chugai) Business Overview
  7.1.3 Roche (Chugai) Bispecific Monoclonal Antibodies Major Product Offerings
  7.1.4 Roche (Chugai) Bispecific Monoclonal Antibodies Revenue in Global (2016-2021)
  7.1.5 Roche (Chugai) Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Bispecific Monoclonal Antibodies Major Product Offerings
  7.2.4 Amgen Bispecific Monoclonal Antibodies Revenue in Global (2016-2021)
  7.2.5 Amgen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bispecific Monoclonal Antibodies Market Opportunities & Trends in Global Market
Table 2. Bispecific Monoclonal Antibodies Market Drivers in Global Market
Table 3. Bispecific Monoclonal Antibodies Market Restraints in Global Market
Table 4. Key Players of Bispecific Monoclonal Antibodies in Global Market
Table 5. Top Bispecific Monoclonal Antibodies Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Bispecific Monoclonal Antibodies Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Bispecific Monoclonal Antibodies Revenue Share by Companies, 2016-2021
Table 8. Global Companies Bispecific Monoclonal Antibodies Product Type
Table 9. List of Global Tier 1 Bispecific Monoclonal Antibodies Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bispecific Monoclonal Antibodies Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Bispecific Monoclonal Antibodies Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Bispecific Monoclonal Antibodies Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Bispecific Monoclonal Antibodies Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Bispecific Monoclonal Antibodies Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Bispecific Monoclonal Antibodies Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Bispecific Monoclonal Antibodies Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2022-2027
Table 30. Roche (Chugai) Corporate Summary
Table 31. Roche (Chugai) Bispecific Monoclonal Antibodies Product Offerings
Table 32. Roche (Chugai) Bispecific Monoclonal Antibodies Revenue (US$, Mn), (2016-2021)
Table 33. Amgen Corporate Summary
Table 34. Amgen Bispecific Monoclonal Antibodies Product Offerings
Table 35. Amgen Bispecific Monoclonal Antibodies Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Bispecific Monoclonal Antibodies Segment by Type
Figure 2. Bispecific Monoclonal Antibodies Segment by Application
Figure 3. Global Bispecific Monoclonal Antibodies Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Bispecific Monoclonal Antibodies Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Bispecific Monoclonal Antibodies Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bispecific Monoclonal Antibodies Revenue in 2020
Figure 8. By Type - Global Bispecific Monoclonal Antibodies Revenue Market Share, 2016-2027
Figure 9. By Application - Global Bispecific Monoclonal Antibodies Revenue Market Share, 2016-2027
Figure 10. By Region - Global Bispecific Monoclonal Antibodies Revenue Market Share, 2016-2027
Figure 11. By Country - North America Bispecific Monoclonal Antibodies Revenue Market Share, 2016-2027
Figure 12. US Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Bispecific Monoclonal Antibodies Revenue Market Share, 2016-2027
Figure 16. Germany Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 17. France Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Bispecific Monoclonal Antibodies Revenue Market Share, 2016-2027
Figure 24. China Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 28. India Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Bispecific Monoclonal Antibodies Revenue Market Share, 2016-2027
Figure 30. Brazil Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Bispecific Monoclonal Antibodies Revenue Market Share, 2016-2027
Figure 33. Turkey Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Bispecific Monoclonal Antibodies Revenue, (US$, Mn), 2016-2027
Figure 37. Roche (Chugai) Bispecific Monoclonal Antibodies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Amgen Bispecific Monoclonal Antibodies Revenue Year Over Year Growth (US$, Mn) & (2016-2021)